A Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets.
Public ClinicalTrials.gov record NCT02271217. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
This is a Multi-center, Double-blind, Three Arm, Parallel Group, Placebo-controlled, Randomized Study Designed to Evaluate the Efficacy, Safety and Tolerability of Dalfampridine.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to determine the effect of two dose strengths of dalfampridine-Extended Release (ER) tablets, taken twice daily for 12 weeks, on stable walking deficits in subjects with post-ischemic stroke.
Study identification
- NCT ID
- NCT02271217
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 377 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2014 (Type not available)
- Primary completion
- Sep 2016 (Actual)
- Completion
- Oct 2016 (Actual)
- Last update posted
- Jun 7, 2018
2014 – 2016
United States locations
- U.S. sites
- 70
- U.S. states
- 28
- U.S. cities
- 64
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Acorda Site #117 | Gilbert | Arizona | 85234 | — |
| Acorda Site #109 | Berkeley | California | 94705 | — |
| Acorda Site #138 | Long Beach | California | 90806 | — |
| Acorda Site #105 | Newport Beach | California | 92663 | — |
| Acorda Site #170 | Oceanside | California | 92056 | — |
| Acorda Site #142 | Pasadena | California | 91105 | — |
| Acorda Site #153 | Sacramento | California | 95823 | — |
| Acorda Site #151 | San Diego | California | 92103 | — |
| Acorda Site #163 | San Diego | California | 92123 | — |
| Acorda Site #124 | Colorado Springs | Colorado | 80907 | — |
| Acorda Site #110 | Danbury | Connecticut | 06810 | — |
| Acorda Site #149 | Fairfield | Connecticut | 06824 | — |
| Acorda Site #130 | Stamford | Connecticut | 06905 | — |
| Acorda Site #115 | Atlantis | Florida | 33462 | — |
| Acorda Site #119 | Deerfield Beach | Florida | 33064 | — |
| Acorda Site #147 | Gainesville | Florida | 32611 | — |
| Acorda Site #128 | Hialeah | Florida | 33012 | — |
| Acorda Site #143 | Jacksonville | Florida | 32209 | — |
| Acorda Site #103 | Miami | Florida | 33142 | — |
| Acorda Site #133 | Miami | Florida | 33175 | — |
| Acorda Site #161 | Naples | Florida | 34102 | — |
| Acorda Site #145 | Sunrise | Florida | 33351 | — |
| Acorda Site #106 | Tampa | Florida | 33606 | — |
| Acorda Site #186 | Atlanta | Georgia | 30309 | — |
| Acorda Site #181 | Kailua | Hawaii | 96734 | — |
| Acorda Site #171 | Chicago | Illinois | 60611 | — |
| Acorda Site #148 | Avon | Indiana | 46123 | — |
| Acorda Site #188 | Fort Wayne | Indiana | 46805 | — |
| Acorda Site #156 | Franklin | Indiana | 46131 | — |
| Acorda Site #146 | Lexington | Kentucky | 40513 | — |
| Acorda Site #150 | New Orleans | Louisiana | 70121 | — |
| Acorda Site #175 | Fulton | Maryland | 20759 | — |
| Acorda Site #136 | Boston | Massachusetts | 02114 | — |
| Acorda Site #121 | Boston | Massachusetts | 02118 | — |
| Acorda Site #120 | Worcester | Massachusetts | 016052610 | — |
| Acorda Site #164 | Bingham Farms | Michigan | 48025 | — |
| Acorda Site #127 | Detroit | Michigan | 48201 | — |
| Acorda Site #123 | East Lansing | Michigan | 48824 | — |
| Acorda Site #159 | Grand Rapids | Michigan | 49503 | — |
| Acorda Site #101 | Kansas City | Missouri | 64132 | — |
| Acorda Site #111 | Great Falls | Montana | 59405 | — |
| Acorda Site #140 | Reno | Nevada | 89502 | — |
| Acorda Site #131 | New Brunswick | New Jersey | 08903 | — |
| Acorda Site #177 | Stratford | New Jersey | 08084 | — |
| Acorda Site #172 | New York | New York | 10029 | — |
| Acorda Site #102 | New York | New York | 11220 | — |
| Acorda Site #179 | Patchogue | New York | 11772 | — |
| Acorda Site #114 | White Plains | New York | 10605 | — |
| Acorda Site #166 | Chapel Hill | North Carolina | 27599 | — |
| Acorda Site #167 | Durham | North Carolina | 27705 | — |
| Acorda Site #162 | Mooresville | North Carolina | 28117 | — |
| Acorda Site #154 | Raleigh | North Carolina | 276076010 | — |
| Acorda Site #132 | Winston-Salem | North Carolina | 27103 | — |
| Acorda Site #187 | Bellevue | Ohio | 44811 | — |
| Acorda Site #160 | Cleveland | Ohio | 44195 | — |
| Acorda Site #137 | Columbus | Ohio | 43210 | — |
| Acorda Site #116 | Dayton | Ohio | 45417 | — |
| Acorda Site #152 | Corvallis | Oregon | 97330 | — |
| Acorda Site #168 | Portland | Oregon | 97225 | — |
| Acorda Site #126 | Portland | Oregon | 97239 | — |
| Acorda Site #158 | Abington | Pennsylvania | 19001 | — |
| Acorda Site #122 | Philadelphia | Pennsylvania | 19104 | — |
| Acorda Site #144 | Providence | Rhode Island | 02903 | — |
| Acorda Site #157 | Memphis | Tennessee | 38163 | — |
| Acorda Site #113 | Dallas | Texas | 75214 | — |
| Acorda Site #165 | Dallas | Texas | 75246 | — |
| Acorda Site #108 | Houston | Texas | 77030 | — |
| Acorda Site #182 | Alexandria | Virginia | 22310 | — |
| Acorda Site #176 | Richmond | Virginia | 23298 | — |
| Acorda Site #107 | Spokane | Washington | 992021330 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02271217, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 7, 2018 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02271217 live on ClinicalTrials.gov.